Quick Takeaways
- Skylands Capital, LLC filed SCHEDULE 13G for CytoSorbents Corporation Common Stock (CTSO).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2024.
Skylands Capital, LLC - 31 Dec 2024 SCHEDULE 13G Report for CytoSorbents Corporation Common Stock (CTSO)
- Filing Manager
- Skylands Capital, LLC
- Reporting Manager
- Skylands Capital, LLC
- Symbol
- CTSO
- Shares outstanding
- 54,541,608 shares
- Disclosed Ownership
- 2,781,622 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Jan 2025, 13:26:16 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 17 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Skylands Capital, LLC disclosed 5.1% ownership in CytoSorbents Corporation Common Stock (CTSO) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Jan 2025, 13:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Skylands Capital, LLC | 5.1% | 2,781,622 | 2,781,622 | 0 | /s/ Virginia E. Shaffar | Virginia E. Shaffar Vice President & Treasurer |